[go: up one dir, main page]

Poli et al., 1997 - Google Patents

Oxidative damage and fibrogenesis

Poli et al., 1997

Document ID
5888406992468520055
Author
Poli G
Parola M
Publication year
Publication venue
Free Radical Biology and Medicine

External Links

Snippet

Various chronic disease processes are characterized by progressive accumulation of connective tissue undergoing fibrotic degeneration. Evidence of oxidative reactions is often associated with fibrogenesis occurring in liver, lung, arteries, and nervous system. Moreover …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Similar Documents

Publication Publication Date Title
Poli et al. Oxidative damage and fibrogenesis
Nairz et al. “Pumping iron”—how macrophages handle iron at the systemic, microenvironmental, and cellular levels
Braidy et al. The precursor to glutathione (GSH), γ-Glutamylcysteine (GGC), can ameliorate oxidative damage and neuroinflammation induced by Aβ40 oligomers in human astrocytes
Ben-Menachem et al. Superoxide dismutase and glutathione peroxidase function in progressive myoclonus epilepsies
Zalewska et al. The role of metallothionein interactions with other proteins
Sturm et al. Recombinant human erythropoietin: effects on frataxin expression in vitro
Fareed et al. Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression
Oram et al. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease
Jeong et al. Interaction of clusterin and matrix metalloproteinase-9 and its implication for epithelial homeostasis and inflammation
Melchor et al. Tissue plasminogen activator in central nervous system physiology and pathology
Arosio et al. Ferritins: a family of molecules for iron storage, antioxidation and more
Champattanachai et al. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc
Tripathy et al. Thrombin, a mediator of cerebrovascular inflammation in AD and hypoxia
Caccamo et al. Age-and region-dependent alterations in Aβ-degrading enzymes: implications for Aβ-induced disorders
Gałecki et al. Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients
Rogers et al. Heme oxygenase-2 knockout neurons are less vulnerable to hemoglobin toxicity
Mulder et al. Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease.
Arul et al. Biotinylated GHK peptide incorporated collagenous matrix: A novel biomaterial for dermal wound healing in rats
Babady et al. Advancements in the pathophysiology of Friedreich’s Ataxia and new prospects for treatments
Lasierra-Cirujeda et al. Beta-amyloidolysis and glutathione in Alzheimer’s disease
Monfort et al. Recent advances in the elucidation of Frataxin biochemical function open novel perspectives for the Treatment of Friedreich’s Ataxia
Jeong et al. Broad activation of the Parkin pathway induces synaptic mitochondrial deficits in early tauopathy
Ahmed et al. Combinatory Effects of Bone Marrow‐Derived Mesenchymal Stem Cells and Indomethacin on Adjuvant‐Induced Arthritis in Wistar Rats: Roles of IL‐1β, IL‐4, Nrf‐2, and Oxidative Stress
Howells et al. Neuronal growth‐inhibitory factor (metallothionein‐3): evaluation of the biological function of growth‐inhibitory factor in the injured and neurodegenerative brain
Walser et al. Growth hormone and neuronal hemoglobin in the brain—roles in neuroprotection and neurodegenerative diseases